Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Baxter
UBS
Johnson and Johnson
US Army
US Department of Justice
Farmers Insurance
Harvard Business School

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203324

« Back to Dashboard

NDA 203324 describes PHOTREXA VISCOUS IN DEXTRAN 20%, which is a drug marketed by Avedro Inc and is included in one NDA. It is available from one supplier. Additional details are available on the PHOTREXA VISCOUS IN DEXTRAN 20% profile page.

The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20% is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.
Summary for 203324
You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM') AND hsdb_drugname IS NOT NULL' at line 1
Tradename:PHOTREXA VISCOUS IN DEXTRAN 20%
Applicant:Avedro Inc
Ingredient:riboflavin 5'-phosphate sodium
Patents:0